I 

115TH CONGRESS 

1ST SESSION H. R. 1732 

To amend the Controlled Substances Act to add certain synthetic substances 

to schedule I, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 27, 2017 

Mr. DENT (for himself, Mr. HIMES, and Mr. BARLETTA) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period 

to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee 

concerned 

A BILL 

To amend the Controlled Substances Act to add certain 

synthetic substances to schedule I, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Synthetic Drug Con5 trol Act of 2017’’. 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 1732 IH

1 SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS 

2 SCHEDULE I CONTROLLED SUBSTANCES. 

3 (a) IN GENERAL.—Not later than 180 days after the 

4 date of enactment of this Act, the Attorney General of 

5 the United States shall update schedule I under section 

6 202(c) of the Controlled Substances Act (21 U.S.C. 

7 812(c)) to include, unless specifically exempted or unless 

8 listed in another schedule, any material, compound, mix9 ture, or preparation which contains any quantity of a sub10 stance listed in paragraphs (1) through (9), or which con11 tains the salts, isomers, and salts of isomers thereof when12 ever the existence of such salts, isomers, and salts of iso13 mers is possible within the specific chemical designation. 

14 The substances referred to in the preceding sentence are 

15 the following: 

16 (1) PHENYLALKYLAMINES.—The substances 

17 listed in this paragraph consist of the following 

18 phenylalkylamines: 

19 (A) 1-(4-Ethylphenyl)-2-(methylamino)-1- 

20 propanone. 

21 (B) 1-(4-Methoxyphenyl)-2-(methylamino)- 

22 1-propanone. 

23 (C) 2-(Ethylamino)-1-(4-methoxyphenyl)-1- 

24 propanone. 

25 (D) 1-(1,3-Benzodioxol-5-yl)-2- 

26 (ethylamino)-1-propanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
3 

•HR 1732 IH

1 (E) 2-(Ethylamino)-1-phenyl-1-propanone. 

2 (F) 1-Phenyl-2-(1-pyrrolidinyl)-1- 

3 propanone. 

4 (G) 1-(4-Methoxyphenyl)-2-(1- 

5 pyrrolidinyl)-1-propanone. 

6 (H) 1-(1,3-Benzodioxol-5-yl)-2-(1- 

7 pyrrolidinyl)-1-propanone. 

8 (I) 2-Amino-1-(4-fluorophenyl)propan-1- 

9 one. 

10 (J) 2-(Ethylamino)-1-(4-ethylphenyl)-1- 

11 propanone. 

12 (K) 2-(Dimethylamino)-1-phenyl-1- 

13 propanone. 

14 (L) 1-(1,3-Benzodioxol-5-yl)-2-(1- 

15 pyrrolidinyl)-1-butanone. 

16 (M) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)- 

17 1-hexanone. 

18 (N) 2-(Methylamino)-1-phenyl-1-butanone. 

19 (O) 2-(Methylamino)-1-(4-methylphenyl)-1- 

20 butanone. 

21 (P) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)- 

22 1-butanone. 

23 (Q) 1-(3,4-Dimethylphenyl)-2- 

24 (methylamino)-1-propanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
4 

•HR 1732 IH

1 (R) 1-(1,3-Benzodioxol-5-yl)-2- 

2 (dimethylamino)-1-propanone. 

3 (S) 2-(Benzylamino)-1-(4-methylphenyl)-1- 

4 propanone. 

5 (T) 1-(1-Naphthyl)-2-(1-pyrrolidinyl)-1- 

6 pentanone. 

7 (U) 1-(1,3-Benzodioxol-5-yl)-2- 

8 (benzylamino)-1-propanone. 

9 (V) 1-(1,3-Benzodioxol-5-yl)-2- 

10 (benzylamino)-1-butanone. 

11 (W) 1-(1,3-Benzodioxol-2-yl)-2-(N-hydroxy12 N-methylamino)-1-propanone. 

13 (X) 1-(1,3-Benzodioxol-5-yl)-2- 

14 (dimethylamino)-1-butanone. 

15 (Y) 2-(Ethyl(methyl)amino)-1-phenylbutan16 1-one. 

17 (Z) 1-(4-Bromophenyl)-2-(methylamino)-1- 

18 propanone. 

19 (AA) 2-[Ethyl(methyl)amino]-1-phenyl-1- 

20 propanone. 

21 (BB) 2-(Methylamino)-1-(3-methylphenyl)- 

22 1-propanone. 

23 (CC) 2-(1-Pyrrolidinyl)-1-(2-thiophenyl)-1- 

24 pentanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
5 

•HR 1732 IH

1 (DD) 1-(4-Fluorophenyl)-2-(methylamino)- 

2 1-butanone. 

3 (EE) 1-(4-Methoxyphenyl)-2-(1- 

4 pyrrolidinyl)-1-butanone. 

5 (FF) 1-(4-Ethylphenyl)-2-(1-pyrrolidinyl)- 

6 1-butanone. 

7 (GG) 1-(4-Methoxy-3-methylphenyl)-2- 

8 (methylamino)-1-propanone. 

9 (HH) 2-(Ethylamino)-1-(3-methylphenyl)- 

10 1-propanone. 

11 (II) 2-Amino-1-(1H-indol-5-yl)-1- 

12 propanone. 

13 (JJ) 1-Phenyl-2-(1-piperidinyl)-1-buta14 none. 

15 (KK) 2-(Methylamino)-1-(2,4,5- 

16 trimethylphenyl)-1-propanone. 

17 (LL) 1-Phenyl-2-(1-pyrrolidinyl)-1- 

18 heptanone. 

19 (MM) 1-Phenyl-2-(1-pyrrolidinyl)-1- 

20 hexanone. 

21 (NN) 1-(4-Fluorophenyl)-2-(1- 

22 pyrrolidinyl)-1-pentanone. 

23 (OO) 1-(1,3-Benzodioxol-5-yl)-2- 

24 (dimethylamino)-1-pentanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
6 

•HR 1732 IH

1 (PP) 1-(2-Fluorophenyl)-N-methyl-2- 

2 propanamine. 

3 (QQ) 1-(2-Fluorophenyl)-2-propanamine. 

4 (RR) 1-(3-Fluorophenyl)-2-propanamine. 

5 (SS) 1-(3-Fluorophenyl)-N-methyl-2- 

6 propanamine. 

7 (TT) 1-(4-Fluorophenyl)-2-propanamine. 

8 (UU) 1-(4-Fluorophenyl)-N-methyl-2- 

9 propanamine. 

10 (VV) 1-(4-Methylphenyl)-2-propanamine. 

11 (WW) N-Ethyl-N-methyl-1-phenyl-2- 

12 propanamine. 

13 (XX) 1-(1-Benzofuran-4-yl)-2- 

14 propanamine. 

15 (YY) 1-(1-Benzofuran-5-yl)-2- 

16 propanamine. 

17 (ZZ) 1-(2,3-Dihydro-1-benzofuran-5-yl)-2- 

18 propanamine. 

19 (AAA) 1-(1-Benzofuran-6-yl)-2- 

20 propanamine. 

21 (BBB) 1-(2,3-Dihydro-1-benzofuran-6-yl)- 

22 2-propanamine. 

23 (CCC) 1-(4-Methoxyphenyl)-N-methyl-2- 

24 propanamine. 


SSpencer on DSK4SPTVN1PROD with BILLS
7 

•HR 1732 IH

1 (DDD) N,N-Dimethyl-1-phenyl-2- 

2 propanamine. 

3 (EEE) 1-(2,3-Dihydro-1H-inden-5-yl)-2- 

4 propanamine. 

5 (FFF) 5,6,7,8-Tetrahydronaphtho[2,3- 

6 d][1,3]dioxol-6-amine. 

7 (GGG) 1-[4-(Methylsulfanyl)phenyl]-2- 

8 propanamine. 

9 (HHH) 1-(4-Chlorophenyl)-2-propanamine. 

10 (III) 1-(2,4,6-Trimethoxyphenyl)-2- 

11 propanamine. 

12 (JJJ) 1-(2,4,5-Trimethoxyphenyl)-2- 

13 propanamine. 

14 (KKK) 1-(2,5-Dimethylphenyl)-2- 

15 propanamine. 

16 (LLL) 1-(3,4-Dimethylphenyl)-2- 

17 propanamine. 

18 (MMM) N-(1-Phenyl-2-propanyl)-1- 

19 propanamine. 

20 (NNN) 1-(1,3-Benzodioxol-5-yl)-N,N-di21 methyl-2-propanamine. 

22 (OOO) N-Ethyl-1-(4-methoxyphenyl)-2- 

23 propanamine. 

24 (PPP) 1-(1-Benzofuran-5-yl)-N-methyl-2- 

25 propanamine. 


SSpencer on DSK4SPTVN1PROD with BILLS
8 

•HR 1732 IH

1 (QQQ) 6,7-Dihydro-5H-indeno[5,6- 

2 d][1,3]dioxol-6-amine. 

3 (RRR) 5-Iodo-2-indanamine. 

4 (SSS) N-Methyl-6,7-dihydro-5H5 indeno[5,6-d][1,3]dioxol-6-amine. 

6 (TTT) N-Methyl-2-indanamine. 

7 (UUU) 2-{4-[(2-Fluoroethyl)sulfanyl]-2,5- 

8 dimethoxyphenyl}ethanamine. 

9 (VVV) 2-(8-Bromo-2,3,6,7- 

10 tetrahydrofuro[2,3-f][1]benzofuran-4- 

11 yl)ethanamine. 

12 (WWW) 2-(2,5-Dimethoxy-3,4- 

13 dimethylphenyl)ethanamine. 

14 (XXX) 2-(2,5-Dimethoxy-4-methylphenyl)- 

15 N-(2-methoxybenzyl)ethanamine. 

16 (YYY) 2-(4-Ethyl-2,5-dimethoxyphenyl)-N17 (2-methoxybenzyl)ethanamine. 

18 (ZZZ) 2-(2,5-Dimethoxy-3,4- 

19 dimethylphenyl)-N-(2-methoxy20 benzyl)ethanamine. 

21 (AAAA) 2-(2,5-Dimethoxyphenyl)-N-(2- 

22 methoxybenzyl)ethanamine. 

23 (BBBB) 2-(2,5-Dimethoxy-4-nitrophenyl)- 

24 N-(2-methoxybenzyl)ethanamine. 


SSpencer on DSK4SPTVN1PROD with BILLS
9 

•HR 1732 IH

1 (CCCC) 1-(8-Bromofuro[2,3- 

2 f][1]benzofuran-4-yl)-2-propanamine. 

3 (DDDD) 1-(4-Chloro-2,5- 

4 dimethoxyphenyl)-2-propanamine. 

5 (EEEE) 1-(8-Bromo-2,3,6,7- 

6 tetrahydrobenzo[1,2-b:4,5-b′]difuran-4- 

7 yl)propan-2-amine. 

8 (FFFF) 1-[4-(Ethylsulfanyl)-2,5- 

9 dimethoxyphenyl]-2-propanamine. 

10 (GGGG) 1-(4-Ethoxy-2,5- 

11 dimethoxyphenyl)-2-propanamine. 

12 (HHHH) 1-[2,5-Dimethoxy-4- 

13 (propylsulfanyl)phenyl]-2-propanamine. 

14 (IIII) 6-Chloro-1,2,3,4-tetrahydro-1- 

15 naphthalenamine. 

16 (JJJJ) N-Methyl-3- 

17 phenylbicyclo[2.2.1]heptan-2-amine. 

18 (KKKK) 1-(2-Methoxyphenyl)-N-methyl-2- 

19 propanamine. 

20 (LLLL) 2-[4-(Allyloxy)-3,5- 

21 dimethoxyphenyl]ethanamine. 

22 (MMMM) 4-Methyl-2-hexanamine. 

23 (NNNN) 4-Methyl-5-phenyl-4,5-dihydro24 1,3-oxazol-2-amine. 


SSpencer on DSK4SPTVN1PROD with BILLS
10 

•HR 1732 IH

1 (OOOO) N-Methyl-1-(2-thienyl)-2- 

2 propanamine. 

3 (PPPP) 3-(Dimethylamino)-2,2- 

4 dimethylpropyl 4-aminobenzoate. 

5 (QQQQ) 4-Methyl-5-(4-methylphenyl)-4,5- 

6 dihydro-1,3-oxazol-2-amine. 

7 (RRRR) 1-Phenyl-2-(1-pyrrolidinyl)-1-pro8 panol. 

9 (2) CANNABIMIMETIC AGENTS.—The sub10 stances listed in this paragraph consist of the fol11 lowing cannabimimetic agents: 

12 (A) (4-Ethyl-1-naphthyl)(1-pentyl-1H13 indol-3-yl)methanone. 

14 (B) 2-(2-Methylphenyl)-1-(1-pentyl-1H15 indol-3-yl)ethanone. 

16 (C) (2-Methyl-1-[(1-methylpiperidin-2- 

17 yl)methyl]-6-nitro-1H-indol-3-yl)(2- 

18 naphthyl)methanone. 

19 (D) (1-Butyl-1H-indol-3-yl)(4- 

20 methoxyphenyl)methanone. 

21 (E) (1-Butyl-1H-indol-3-yl)(4-methyl-1- 

22 naphthyl)methanone. 

23 (F) [1-(5-Fluoropentyl)-1H-indol-3-yl](4- 

24 methyl-1-naphthyl)methanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
11 

•HR 1732 IH

1 (G) {1-[(1-Methyl-2-piperidinyl)methyl]- 

2 1H-indol-3-yl}(1-naphthyl)methanone. 

3 (H) 2-(3-Methoxyphenyl)-1-(1-pentyl-1H4 indol-3-yl)ethanone. 

5 (I) (2-Iodophenyl){1-[(1-methyl-2- 

6 piperidinyl)methyl]-1H-indol-3-yl}methanone. 

7 (J) Adamantan-1-yl{1-[(1-methyl-2- 

8 piperidinyl)methyl]-1H-indol-3-yl}methanone. 

9 (K) 1-Naphthyl(1-propyl-1H-indol-3- 

10 yl)methanone. 

11 (L) 5-[3-(1-Naphthoyl)-1H-indol-1- 

12 yl]pentanenitrile. 

13 (M) 3-(1-Naphthylmethyl)-1-pentyl-1H14 indole. 

15 (N) (2-Methyl-1-propyl-1H-indol-3-yl)(1- 

16 naphthyl)methanone. 

17 (O) 1-Naphthyl[1-(4-penten-1-yl)-1H-indol18 3-yl]methanone. 

19 (P) (4-Bromo-1-naphthyl)(1-pentyl-1H20 indol-3-yl)methanone. 

21 (Q) (4-Fluoro-1-naphthyl)(1-pentyl-1H22 indol-3-yl)methanone. 

23 (R) (1-Naphthyl)(1-phenyl-1H-indol-3- 

24 yl)methanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
12 

•HR 1732 IH

1 (S) [1-(5-Chloropentyl)-1H-indol-3-yl](2- 

2 iodophenyl)methanone. 

3 (T) Adamantan-1-yl(1-pentyl-1H-indol-3- 

4 yl)methanone. 

5 (U) (2-Iodo-5-nitrophenyl){1-[(1-methyl-2- 

6 piperidinyl)methyl]-1H-indol-3-yl}methanone. 

7 (V) {1-[2-(4-Morpholinyl)ethyl]-1H-indol8 3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone. 

9 (W) [1-(Tetrahydro-2H-pyran-4-ylmethyl)- 

10 1H-indol-3-yl](2,2,3,3- 

11 tetramethylcyclopropyl)methanone. 

12 (X) N-(Adamantan-1-yl)-1-pentyl-1H13 indole-3-carboxamide. 

14 (Y) N-(Adamantan-1-yl)-1-(5- 

15 fluoropentyl)-1H-indole-3-carboxamide. 

16 (Z) [1-(5-Chloropentyl)-1H-indol-3- 

17 yl](2,2,3,3-tetramethylcyclopropyl)methanone. 

18 (AA) [1-(3-Methylbutyl)-1H-indol-3-yl](1- 

19 naphthyl)methanone. 

20 (BB) N-(Adamantan-1-yl)-1-(5- 

21 fluoropentyl)-1H-indazole-3-carboxamide. 

22 (CC) (1-Pentyl-1H-indol-3-yl)(4-propyl-1- 

23 naphthyl)methanone. 

24 (DD) [1-(5-Chloropentyl)-1H-indol-3- 

25 yl](2,2,3,3-tetramethylcyclopropyl)methanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
13 

•HR 1732 IH

1 (EE) (4-Methyl-1-naphthyl)[1-(4-penten-1- 

2 yl)-1H-indol-3-yl]methanone. 

3 (FF) (2-Methoxy-1-naphthyl)(1-pentyl-1H4 indol-3-yl)methanone. 

5 (GG) (3-Methoxyphenyl)(1-pentyl-1H6 indol-3-yl)methanone. 

7 (HH) (4-Ethyl-1-naphthyl)[1-(5- 

8 fluoropentyl)-1H-indol-3-yl]methanone. 

9 (II) 8-Quinolinyl 1-(cyclohexylmethyl)-1H10 indole-3-carboxylate. 

11 (JJ) 1-(5-Fluoropentyl)-N-(1-naphthyl)- 

12 1H-indole-3-carboxamide. 

13 (KK) N-(1-Amino-3,3-dimethyl-1-oxo-2- 

14 butanyl)-1-(4-fluorobenzyl)-1H-indazole-3- 

15 carboxamide. 

16 (LL) N-(1-Amino-3,3-dimethyl-1-oxo-2- 

17 butanyl)-1-pentyl-1H-indole-3-carboxamide. 

18 (MM) (2-Iodophenyl)(1-pentyl-1H-indol-3- 

19 yl)methanone. 

20 (NN) [5-(2-Methylphenyl)-1-pentyl-1H21 pyrrol-3-yl](1-naphthyl)methanone. 

22 (OO) N-(1-Naphthyl)-1-pentyl-1H-indole23 3-carboxamide. 

24 (PP) [1-(5-Chloropentyl)-1H-indol-3-yl](4- 

25 methyl-1-naphthyl)methanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
14 

•HR 1732 IH

1 (QQ) (4-Methyl-1-naphthyl)(2-methyl-1- 

2 pent-4-enyl-1H-indol-3-yl)methanone. 

3 (RR) (2-Methylphenyl)[1-(5-fluoropentyl)- 

4 1H-indol-3-yl]methanone. 

5 (SS) (2-Ethylphenyl)[1-(5-fluoropentyl)- 

6 1H-indol-3-yl]methanone. 

7 (TT) [1-(5-Chloropentyl)-1H-indol-3-yl](1- 

8 naphthyl)methanone. 

9 (UU) [1-(5-Bromopentyl)-1H-indol-3-yl](1- 

10 naphthyl)methanone. 

11 (VV) {1-[(1-Methyl-2-piperidinyl)methyl]- 

12 1H-indol-3-yl}(2,2,3,3- 

13 tetramethylcyclopropyl)methanone. 

14 (WW) [1-(1-Methylazepan-2-yl)-1H-indol15 3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. 

16 (XX) 4-Hydroxy-3,3,4-trimethyl-1-(1- 

17 pentyl-1H-indol-3-yl)-1-pentanone. 

18 (YY) [1-(4-Fluoropentyl)-1H-indol-3-yl](1- 

19 naphthyl)methanone. 

20 (ZZ) 2-(2-Iodophenyl)-1-(1-pentyl-1H21 indol-3-yl)-1-ethanone. 

22 (AAA) (2,2,3,3-Tetramethylcyclopropyl)(1- 

23 butyl-1H-indol-3-yl)methanone. 

24 (BBB) (2,2,3,3-Tetramethylcyclopropyl)[1- 

25 (4,4,4-trifluorobutyl)-1H-indol-3-yl]methanone. 


SSpencer on DSK4SPTVN1PROD with BILLS
15 

•HR 1732 IH

1 (CCC) 7-Methoxy-1-[2-(4- 

2 morpholinyl)ethyl]-N-[(1S,4R)-1,3,3- 

3 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3 

4 -carboxamide. 

5 (DDD) 8-Quinolinyl 1-(4-fluorobenzyl)-1H6 indole-3-carboxylate. 

7 (EEE) 1-Naphthyl 1-(4-fluorobenzyl)-1H8 indole-3-carboxylate. 

9 (FFF) N-(1-Amino-3,3-dimethyl-1-oxo-2- 

10 butanyl)-1-(5-fluoropentyl)-1H-indole-3- 

11 carboxamide. 

12 (GGG) [1-(4-Fluoropentyl)-1H-indol-3- 

13 yl](2,2,3,3-tetramethylcyclopropyl)methanone. 

14 (HHH) 1-Naphthyl(1-pentyl-1H-indazol-3- 

15 yl)methanone. 

16 (III) N-(1-Naphthyl)-1-pentyl-1H-indazole17 3-carboxamide. 

18 (JJJ) 1-Naphthyl 1-(5-fluoropentyl)-1H19 indole-3-carboxylate. 

20 (KKK) Methyl 3-methyl-2-[(1- 

21 pentylindazole-3-carbonyl)amino]butanoate. 

22 (LLL) Methyl 2-[[1-(5- 

23 fluoropentyl)indazole-3-carbonyl]amino]-3- 

24 methylbutanoate. 


SSpencer on DSK4SPTVN1PROD with BILLS
16 

•HR 1732 IH

1 (MMM) N-Benzyl-1-pentyl-1H-indole-3- 

2 carboxamide. 

3 (NNN) N-Benzyl-1-(5-fluoropentyl)-1H4 indole-3-carboxamide. 

5 (OOO) Methyl 2-({1-[(4- 

6 fluorophenyl)methyl]-1H-indazol-3- 

7 yl}formamido)-3-methylbutanoate. 

8 (PPP) 8-Quinolinyl 1-pentyl-1H-indazole9 3-carboxylate. 

10 (QQQ) 8-Quinolinyl 1-(5-fluoropentyl)-1H11 indazole-3-carboxylate. 

12 (RRR) 2-Naphthyl 1-(2-fluorophenyl)-1H13 indazole-3-carboxylate. 

14 (SSS) [1-(4-Fluorobenzyl)-1H-indol-3- 

15 yl](2,2,3,3-tetramethylcyclopropyl)methanone. 

16 (TTT) 2-{[1-(5-Fluoropentyl)-1H-indol-3- 

17 yl]formamido}-3-phenylpropanamide. 

18 (UUU) 2-{[1-(5-Fluoropentyl)-1H-indazol19 3-yl]formamido}-3-phenylpropanamide. 

20 (VVV) Methyl 2-{[1-(cyclohexylmethyl)- 

21 1H-indol-3-yl]formamido}-3-methylbutanoate. 

22 (WWW) Methyl 2-[[1- 

23 (Cyclohexylmethyl)indazole-3-carbonyl]amino]- 

24 3,3-dimethylbutanoate. 


SSpencer on DSK4SPTVN1PROD with BILLS
17 

•HR 1732 IH

1 (XXX) Methyl 2-{[1-(cyclohexylmethyl)- 

2 1H-indol-3-yl]formamido}-3,3- 

3 dimethylbutanoate. 

4 (YYY) [1-(5-Fluoropentyl)-1H5 benzimidazol-2-yl](1-naphthyl)methanone. 

6 (ZZZ) [1-(4-Fluorobenzyl)-1H-indol-3- 

7 yl](1-naphthyl)methanone. 

8 (AAAA) Methyl 2-({1-[(4- 

9 fluorophenyl)methyl]-1H-indazol-3- 

10 yl}formamido)-3,3-dimethylbutanoate. 

11 (BBBB) 8-Quinolinyl 1-(4-fluorobenzyl)- 

12 1H-indazole-3-carboxylate. 

13 (CCCC) N-(Adamantan-1-yl)-1-(4- 

14 fluorobenzyl)-1H-indazole-3-carboxamide. 

15 (DDDD) N-(1-Amino-3-methyl-1-oxo-2- 

16 butanyl)-1-(5-fluoropentyl)-1H-indole-3- 

17 carboxamide. 

18 (EEEE) 2-[(1S,3R)-3-Hydroxycyclohexyl]- 

19 5-(2-methyl-2-heptanyl)phenol. 

20 (FFFF) 2-[(1S,3R)-3-Hydroxycyclohexyl]- 

21 5-(2-methyl-2-dodecanyl)phenol. 

22 (GGGG) 3-Hydroxy-2-[(1R)-6-isopropenyl23 3-methyl-cyclohex-2-en-1-yl]-5-pentyl-1,4- 

24 benzoquinone. 


SSpencer on DSK4SPTVN1PROD with BILLS
18 

•HR 1732 IH

1 (HHHH) {4-[2,6-Dimethoxy-4-(2-methyl2 2-octanyl)phenyl]-6,6- 

3 dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol. 

4 (IIII) 1-Naphthyl[4-(pentyloxy)-1- 

5 naphthyl]methanone. 

6 (JJJJ) 3-{[2-(Hydroxymethyl)-2,3- 

7 dihydro-1H-inden-4-yl]oxy}phenyl 4,4,4- 

8 trifluoro-1-butanesulfonate. 

9 (KKKK) N-(1,3-Benzodioxol-5-ylmethyl)- 

10 7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydro-3- 

11 quinolinecarboxamide. 

12 (LLLL) N-[3-(2-Methoxyethyl)-4,5-di13 methyl-2,3-dihydro-1,3-thiazol-2-ylidene]- 

14 2,2,3,3-tetramethylcyclopropane-1-carboxamide. 

15 (MMMM) [5-(2-Fluorophenyl)-1-pentyl16 1H-pyrrol-3-yl](1-naphthyl)methanone. 

17 (NNNN) 5-(4-Biphenylylmethyl)-N,N-di18 methyl-1H-tetrazole-1-carboxamide. 

19 (OOOO) 6-Methyl-2-[(4- 

20 methylphenyl)amino]-4H-3,1-benzoxazin-4-one. 

21 (PPPP) 4-Hydroxy-N-[2-(4- 

22 hydroxyphenyl)ethyl]-3- 

23 (pentylamino)benzamide. 


SSpencer on DSK4SPTVN1PROD with BILLS
19 

•HR 1732 IH

1 (3) ARYLCYCLOHEXAMINES.—The substances 

2 listed in this paragraph consist of the following 

3 arylcyclohexamines: 

4 (A) 1-(3-Methoxyphenyl)-N5 propylcyclohexanamine. 

6 (B) 2-(Ethylamino)-2-(3- 

7 methoxyphenyl)cyclohexanone. 

8 (C) 1-Phenylcyclohexanamine. 

9 (D) 1-[1-(1-Benzothiophen-2- 

10 yl)cyclohexyl]piperidine. 

11 (E) 1-[1-(4- 

12 Methylphenyl)cyclohexyl]piperidine. 

13 (F) 1(4-Methoxyphenyl)-N14 propylcyclohexanamine. 

15 (G) 1-[1-(4- 

16 Methoxyphenyl)cyclohexyl]piperidine. 

17 (H) 1-[1-(3- 

18 Methoxyphenyl)cyclohexyl]piperidine. 

19 (I) 1-Phenyl-N-propylcyclohexanamine. 

20 (J) N-(2-Methoxyethyl)-1- 

21 phenylcyclohexanamine. 

22 (K) N-(2-Ethoxyethyl)-1- 

23 phenylcyclohexanamine. 

24 (L) N-(3-Methoxypropyl)-1- 

25 phenylcyclohexanamine. 


SSpencer on DSK4SPTVN1PROD with BILLS
20 

•HR 1732 IH

1 (M) 3-[1-(1-Piperidinyl)cyclohexyl]phenol. 

2 (N) 2-(4-Methoxyphenyl)-2- 

3 (methylamino)cyclohexanone. 

4 (O) 2-(2-Chlorophenyl)-2- 

5 (ethylamino)cyclohexanone. 

6 (4) TRYPTAMINES.—The substances listed in 

7 this paragraph consist of the following tryptamines: 

8 (A) 2-(1H-Indol-3-yl)-N-methylethanamine. 

9 (B) N-[2-(1H-Indol-3-yl)ethyl]-N-methyl-2- 

10 propanamine. 

11 (C) N-[2-(1H-Indol-3-yl)ethyl]-N-isopropyl12 2-propanamine. 

13 (D) N-[2-(1H-Indol-3-yl)ethyl]-N-propyl-1- 

14 propanamine. 

15 (E) 3-(2-(Diethylamino)ethyl)-1H-indol-4- 

16 yl acetate. 

17 (F) 3-{2-[Isopropyl(methyl)amino]ethyl}- 

18 1H-indol-4-ol. 

19 (G) 3-[2-(Diisopropylamino)ethyl]-1H20 indol-4-yl acetate. 

21 (H) 3-{2-[Isopropyl(methyl)amino]ethyl}- 

22 1H-indol-4-yl acetate. 

23 (I) 3-[2-(Dimethylamino)ethyl]-1H-indol-4- 

24 yl acetate. 


SSpencer on DSK4SPTVN1PROD with BILLS
21 

•HR 1732 IH

1 (J) 3-[2-(Diethylamino)ethyl]-1H-indol-4- 

2 ol. 

3 (K) 3-[2-(Diisopropylamino)ethyl]-1H4 indol-4-ol. 

5 (L) 3-{2-[Ethyl(methyl)amino]ethyl}-1H6 indol-4-ol. 

7 (M) 3-{2-[Ethyl(methyl)amino]ethyl}-1H8 indol-4-yl acetate. 

9 (N) 3-[2-(Dipropylamino)ethyl]-1H-indol10 4-ol. 

11 (O) 3-[2-(Dipropylamino)ethyl]-1H-indol-4- 

12 yl acetate. 

13 (P) N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)- 

14 N-methylpropan-2-amine. 

15 (Q) 1-(5-Methoxy-1H-indol-3-yl)-2- 

16 propanamine. 

17 (R) 3-[2-(Dimethylamino)ethyl]-1H-indol18 5-yl acetate. 

19 (S) N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]- 

20 N-propylpropan-2-amine. 

21 (T) N,N-Diethyl-2-(5-methoxy-1H-indol-3- 

22 yl)ethanamine. 

23 (U) N-Ethyl-2-(5-methoxy-1H-indol-3-yl)- 

24 N-methylethanamine. 


SSpencer on DSK4SPTVN1PROD with BILLS
22 

•HR 1732 IH

1 (5) BENZYLPIPERIDINES.—The substances list2 ed in this paragraph consist of the following 

3 benzylpiperidines: 

4 (A) 2-(Diphenylmethyl)piperidine. 

5 (B) 2-(Diphenylmethyl)pyrrolidine. 

6 (C) Diphenyl(2-pyrrolidinyl)methanol. 

7 (D) Methyl (3,4-dichlorophenyl)(2- 

8 piperidinyl)acetate. 

9 (E) Methyl (3-chlorophenyl)(2- 

10 piperidinyl)acetate. 

11 (F) Methyl (4-methylphenyl)(2- 

12 piperidinyl)acetate. 

13 (G) Methyl (4-fluorophenyl)(2- 

14 piperidinyl)acetate. 

15 (H) Ethyl phenyl(2-piperidinyl)acetate. 

16 (6) BENZODIAZEPINES.—The substances listed 

17 in this paragraph consist of the following 

18 benzodiazepines: 

19 (A) 4-(2-Chlorophenyl)-2-ethyl-9-methyl20 6H-thieno[3,2-f][1,2,4]triazolo[4,3- 

21 a][1,4]diazepine. 

22 (B) 7-Bromo-5-(2-chlorophenyl)-1,3- 

23 dihydro-2H-1,4-benzodiazepin-2-one. 

24 (C) 8-Bromo-1-methyl-6-phenyl-4H25 [1,2,4]triazolo[4,3-a][1,4]benzodiazepine. 


SSpencer on DSK4SPTVN1PROD with BILLS
23 

•HR 1732 IH

1 (D) 3-Methyl-6-[3- 

2 (trifluoromethyl)phenyl][1,2,4]triazolo[4,3- 

3 b]pyridazine. 

4 (7) OPIOIDS AND OPIOID-LIKE SUBSTANCES.— 

5 The substances listed in this paragraph consist of 

6 the following opioids and opioid-like substances: 

7 (A) 3-[2-(2-Amino-2-propanyl)-1- 

8 hydroxycyclohexyl]phenol. 

9 (B) 2-Methyl-N-phenyl-N-[1-(1-phenyl-2- 

10 propanyl)-4-piperidinyl]propanamide. 

11 (C) 1-Cyclohexyl-4-(1,2- 

12 diphenylethyl)piperazine. 

13 (D) N-Phenyl-N-[1-(2-thiophenylethyl)-4- 

14 piperidinyl]acetamide. 

15 (8) PIPERAZINES.—The substances listed in 

16 this paragraph consist of the following piperazines: 

17 (A) 1,4-Dibenzylpiperazine. 

18 (B) 1-(4-Bromo-2,5- 

19 dimethoxybenzyl)piperazine. 

20 (C) 1-(4-Fluorophenyl)piperazine. 

21 (D) 1-(2-Methoxyphenyl)piperazine. 

22 (E) 1-(4-Chlorophenyl)piperazine. 

23 (F) 1-(4-Methoxyphenyl)piperazine. 

24 (G) 1-(3-Methylbenzyl)piperazine. 

25 (H) 1-Benzyl-4-methylpiperazine. 


SSpencer on DSK4SPTVN1PROD with BILLS
24 

•HR 1732 IH

1 (9) TROPANE AND ALKALOIDS.—The sub2 stances listed in this paragraph consist of the fol3 lowing tropane alkaloids: 

4 (A) 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4- 

5 fluorobenzoate. 

6 (B) Methyl 3-(4-fluorophenyl)-8-methyl-8- 

7 azabicyclo[3.2.1]octane-2-carboxylate. 

8 (b) INAPPLICABILITY OF OTHER PROCESS AND CON9 SIDERATIONS.—The Attorney General of the United 

10 States may carry out subsection (a) without regard to the 

11 process and considerations that are otherwise applicable 

12 under section 201 of the Controlled Substances Act (21 

13 U.S.C. 811) for adding, removing, or transferring con14 trolled substances to, from, or among the schedules under 

15 section 202(c) of such Act (21 U.S.C. 812(c)). 

16 (c) EXEMPTION FOR RESEARCH.— 

17 (1) EXEMPTION.—Notwithstanding subsection 

18 (a), a material, compound, mixture, or preparation 

19 described in such subsection shall not be treated as 

20 a controlled substance for purposes of the Controlled 

21 Substances Act (21 U.S.C. 801 et seq.) so long as 

22 the material, compound, mixture, or preparation is 

23 manufactured, distributed, and used exclusively for 

24 qualified research. 


SSpencer on DSK4SPTVN1PROD with BILLS
25 

•HR 1732 IH

1 (2) QUALIFIED RESEARCH DEFINED.—In this 

2 subsection, the term ‘‘qualified research’’ means re3 search (as such term is used in section 303(f) of the 

4 Controlled Substances Act (21 U.S.C. 823(f))) that 

5 is conducted by a practitioner who is registered 

6 under such section 303(f) to conduct research with 

7 controlled substances in schedule II, III, IV, or V 

8 (as described in such section 303(f)). 

9 (d) RULE OF CONSTRUCTION.—Nothing in this sec10 tion shall be construed to limit or affect the authority of 

11 the Attorney General of the United States to add, remove, 

12 or transfer controlled substances to, from, or among the 

13 schedules under section 202(c) of the Controlled Sub14 stances Act (21 U.S.C. 812(c)), including controlled sub15 stances that have been added to a schedule pursuant to 

16 subsection (a). 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS